Development of an enzyme-linked immunosorbent spot assay to measure serum-neutralizing antibodies against coxsackievirus B3

Clinical and Vaccine Immunology

Volumn 21, Issue 3, 2014, Pages 312-320

  Yang, Lisheng ^a   He, Delei ^a   Tang, Min ^a   Li, Zhiqun ^a   Liu, Che ^a   Xu, Longfa ^a   Chen, Yixin ^a   Du, Hailian ^a   Zhao, Qinjian ^a   Zhang, Jun ^a   Cheng, Tong ^a   Xia, Ningshao ^a  

^a XIAMEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

NEUTRALIZING ANTIBODY; PROTEIN VP1;

ANIMAL EXPERIMENT; ANTIBODY AFFINITY; ANTIBODY DETECTION; ANTIBODY TITER; ANTIGEN ANTIBODY REACTION; ARTICLE; CHILD; COXSACKIE VIRUS B3; CYTOPATHOGENIC EFFECT; DIAGNOSTIC TEST ACCURACY STUDY; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; HUMAN; INCUBATION TIME; INTERMETHOD COMPARISON; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SERODIAGNOSIS; VIRUS CONCENTRATION; VIRUS INFECTIVITY; VIRUS NEUTRALIZATION;

ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; ENTEROVIRUS B, HUMAN; ENZYME-LINKED IMMUNOSPOT ASSAY; HUMANS; NEUTRALIZATION TESTS; TIME FACTORS;

EID: 84896750463     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00359-13     Document Type: Article

References (45)

1. Haarmann CM, Schwimmbeck PL, Mertens T, Schultheiss HP, Strauer BE. 1994. Identification of serotype-specific and nonserotype-specific B-cell epitopes of coxsackie B virus using synthetic peptides. Virology 200: 381-389. http://dx.doi.org/10.1006/viro.1994.1202.
2. Melnick JL. 1996. Enteroviruses: polioviruses, coxsackieviruses, echoviruses, and newer enteroviruses, p 655-712. In Fields BN, Howley PM, Chanock RM, Melnick JL, Monath TP, Roizman B, Straus SE (ed), Fields virology. Lippincott-Raven, Philadelphia, PA.
3. Imrie C, Ferguson J, Sommerville R. 1977. Coxsackie and mumpsvirus infection in a prospective study of acute pancreatitis. Gut 18:53-56. http://dx.doi.org/10.1136/gut.18.1.53. (Pubitemid 8107253)
4. Yoon JW, Austin M, Onodera T, Notkins AL. 1979. Virus-induced diabetes mellitus - isolation of a virus from the pancreas of a child with diabetic ketoacidosis. N. Engl. J. Med. 300:1173-1179. http://dx.doi.org/10.1056/ NEJM197905243002102. (Pubitemid 9191515)
5. Clements GB, Galbraith DN, Taylor KW. 1995. Coxsackie B virus infection and onset of childhood diabetes. Lancet 346:221. http://dx.doi.org/10.1016/ S0140-6736(95)91270-3.
6. Kawai C. 1999. From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death: learning from the past for the future. Circulation 99:1091-1100. http://dx.doi.org/10.1161/01.CIR.99.8.1091. (Pubitemid 29104501)
7. Godney EK, Arizpe HM, Gaunti CJ. 1987. Characterization of the antibody response in vaccinated mice protected against coxsackievirus B3-induced myocarditis. Viral Immunol. 1:305-314. http://dx.doi.org/10.1089/vim.1987.1.305.
8. Henke A, Jarasch N, Wutzler P. 2003. Vaccination procedures against coxsackievirus-induced heart disease. Expert Rev. Vaccines 2:805-815. http://dx.doi.org/10.1586/14760584.2.6.805. (Pubitemid 37541566)
9. McKinney RE, Jr, Katz SL, Wilfert CM. 1987. Chronic enteroviral meningoencephalitis in agammaglobulinemic patients. Rev. Infect. Dis. 9:334-356. http://dx.doi.org/10.1093/clinids/9.2.334.
10. WHO. 1997. Manual for the virological investigation of polio. Global Programme for Vaccines and Immunization, Expanded Programme on Immunization, World Health Organization, Geneva, Switzerland. http://whqlibdoc.who.int/hq/ 1997/WHO-EPI-GEN-97.01.pdf.
11. Plummer G, Benyesh-Melnick M. 1964. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine, New York, NY.
12. Roehrig JT, Hombach J, Barrett AD. 2008. Guidelines for plaque-reduction neutralization testing of human antibodies to dengue viruses. Viral Immunol. 21:123-132. http://dx.doi.org/10.1089/vim.2008.0007. (Pubitemid 351873374)
13. Coates HV, Alling DW, Chanock RM. 1966. An antigenic analysis of respiratory syncytial virus isolates by a plaque reduction neutralization test. Am. J. Epidemiol. 83:299-313.
14. Kalyuzhny AE. 2005. Handbook of ELISPOT: methods and protocols, vol 302. Humana Press, Totowa, NJ.
15. Czerkinsky CC, Nilsson LA, Nygren H, Ouchterlony O, Tarkowski A. 1983. A solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells. J. Immunol. Methods 65:109-121. http://dx.doi.org/10. 1016/0022-1759(83)90308-3. (Pubitemid 14203438)
16. Sedgwick JD, Holt PG. 1983. A solid-phase immunoenzymatic technique for the enumeration of specific antibody-secreting cells. J. Immunol. Methods. 57:301-309. http://dx.doi.org/10.1016/0022-1759(83)90091-1. (Pubitemid 13116746)
17. Abai AM, Smith LR, Wloch MK. 2007. Novel microneutralization assay for HCMV using automated data collection and analysis. J. Immunol. Methods. 322:82-93. http://dx.doi.org/10.1016/j.jim.2007.02.001. (Pubitemid 46560583)
18. Rodrigo WW, Alcena DC, Rose RC, Jin X, Schlesinger JJ. 2009. An automated Dengue virus microneutralization plaque assay performed in human Fc{gamma} receptor-expressing CV-1 cells. Am. J. Trop. Med. Hyg. 80:61-65.
19. Reed LJ, Muench H. 1938. A simple method of estimating fifty per cent endpoints. Am. J. Epidemiol. 27:493-497.
20. Ma JK, Hikmat BY, Wycoff K, Vine ND, Chargelegue D, Yu L, Hein MB, Lehner T. 1998. Characterization of a recombinant plant monoclonal secretory antibody and preventive immunotherapy in humans. Nat. Med. 4:601-606. http://dx.doi.org/10.1038/nm0598-601. (Pubitemid 28237360)
21. Chen Y, Li C, He D, Cheng T, Ge S, Shih JW, Zhao Q, Chen PJ, Zhang J, Xia N. 2012. Antigenic analysis of divergent genotypes human enterovirus 71 viruses by a panel of neutralizing monoclonal antibodies: current genotyping of EV71 does not reflect their antigenicity. Vaccine 32:425-430. http://dx.doi.org/10. 1016/j.vaccine.2012.10.032.
22. Nakane P, Kawaoi A. 1974. Peroxidase-labeled antibody. A new method of conjugation. J. Histochem. Cytochem. 22:1084-1091. http://dx.doi.org/10.1177/22. 12.1084.
23. Dulbecco R, Vogt M. 1954. One-step growth curve of Western equine encephalomyelitis virus on chicken embryo cells grown in vitro and analysis of virus yields from single cells. J. Exp. Med. 99:183-199. http://dx.doi.org/10. 1084/jem.99.2.183.
24. Andrewes CH, Elford WJ. 1933. Observations on anti-phage sera. I: "The percentage law". Br. J. Exp. Pathol. 14:367-376.
25. Dulbecco R, Vogt M, Strickland AG. 1956. A study of the basic aspects of neutralization of two animal viruses, western equine encephalitis virus and poliomyelitis virus. Virology 2:162-205. http://dx.doi.org/10.1016/0042-6822(56) 90017-4.
26. Dimmock NJ. 1993. Neutralization of animal viruses. Curr. Top. Microbiol. Immunol. 183:1-149.
27. Mandel B. 1978. Neutralization of animal viruses. Adv. Virus Res. 23:205-268. (Pubitemid 10176146)
28. Nara PL, Hatch WC, Dunlop NM, Robey WG, Arthur LO, Gonda MA, Fischinger PJ. 1987. Simple, rapid, quantitative, syncytium-forming microassay for the detection of human immunodeficiency virus neutralizing antibody. AIDS Res. Hum. Retroviruses 3:283-302. http://dx.doi.org/10.1089/aid.1987.3.283. (Pubitemid 18040413)
29. Zha JF, Xiao CY, Zuo MZ. 2008. Research progress in vitro detection of vaccine neutralizing antibody. Chinese Medicinal Biotechnology 3:374-377.
30. Zielinska E, Liu D, Wu HY, Quiroz J, Rappaport R, Yang DP. 2005. Development of an improved microneutralization assay for respiratory syncytial virus by automated plaque counting using imaging analysis. Virol. J. 2:84. http://dx.doi.org/10.1186/1743-422X-2-84.
31. Wang Z, Mo C, Kemble G, Duke G. 2004. Development of an efficient fluorescence-based microneutralization assay using recombinant human cytomegalovirus strains expressing green fluorescent protein. J. Virol. Methods 120:207-215. http://dx.doi.org/10.1016/j.jviromet.2004.05.010. (Pubitemid 39037410)
32. Kolokoltsov AA, Davey RA. 2004. Rapid and sensitive detection of retrovirus entry by using a novel luciferase-based content-mixing assay. J. Virol. 78: 5124-5132. http://dx.doi.org/10.1128/JVI.78.10.5124-5132.2004. (Pubitemid 38581464)
33. Arya SC, Agarwal N. 2012. Poliovirus neutralization test with poliovirus pseudovirus to measure neutralizing antibody in humans. Clin. Vaccine Immunol. 19:458. http://dx.doi.org/10.1128/CVI.05568-11.
34. Pierson TC, Sánchez MD, Puffer BA, Ahmed AA, Geiss BJ, Valentine LE, Altamura LA, Diamond MS, Doms RW. 2006. A rapid and quantitative assay for measuring antibody-mediated neutralization of West Nile virus infection. Virology 346:53-65. http://dx.doi.org/10.1016/j.virol.2005.10.030. (Pubitemid 43254699)
35. Huang ML, Chiang PS, Luo ST, Liou GY, Lee MS. 2010. Development of a high-throughput assay for measuring serum neutralizing antibody against enterovirus 71. J. Virol. Methods 165:42-45. http://dx.doi.org/10.1016/j. jviromet.2009.12.015.
36. Ivanov AP, Dragunsky EM. 2005. ELISA as a possible alternative to the neutralization test for evaluating the immune response to poliovirus vaccines. Expert Rev. Vaccines 4:167-172. http://dx.doi.org/10.1586/14760584.4.2.167. (Pubitemid 40525058)
37. Muhamuda K, Madhusudana SN, Ravi V. 2007. Development and evaluation of a competitive ELISA for estimation of rabies neutralizing antibodies after post-exposure rabies vaccination in humans. Int. J. Infect. Dis. 11:441-445. http://dx.doi.org/10.1016/j.ijid.2006.09.013. (Pubitemid 47243811)
38. Smith JS, Yager PA, Baer GM. 1973. A rapid reproducible test for determining rabies neutralizing antibody. Bull. World Health Organ. 48:535-541.
39. Rey F, Barré-Sinoussi F, Schmidtmayerova H, Chermann JC. 1987. Detection and titration of neutralizing antibodies to HIV using an inhibition of the cytopathic effect of the virus on MT4 cells. J. Virol. Methods 16:239-249. http://dx.doi.org/10.1016/0166-0934(87)90008-5. (Pubitemid 17121221)
40. Earl PL, Americo JL, Moss B. 2003. Development and use of a vaccinia virus neutralization assay based on flow cytometric detection of green fluorescent protein. J. Virol. 77:10684-10688. http://dx.doi.org/10.1128/JVI.77. 19.10684-10688.2003. (Pubitemid 37129714)
41. Kraus AA, Messer W, Haymore LB, de Silva AM. 2007. Comparison of plaque-and flow cytometry-based methods for measuring dengue virus neutralization. J. Clin. Microbiol. 45:3777-3780. http://dx.doi.org/10.1128/JCM. 00827-07. (Pubitemid 350156883)
42. Sashihara J, Burbelo PD, Savoldo B, Pierson TC, Cohen JI. 2009. Human antibody titers to Epstein-Barr Virus (EBV) gp350 correlate with neutralization of infectivity better than antibody titers to EBV gp42 using a rapid flow cytometry-based EBV neutralization assay. Virology 391: 249-256. http://dx.doi.org/10.1016/j.virol.2009.06.013.
43. Burnet F, Keogh EV, Lush D. 1937. The immunological reactions of the filterable viruses. Immunology Cell Biol. 15:227-368. http://dx.doi.org/10.1038/ icb.1937.23.
44. Brioen P, Boxyé A. 1985. Poliovirus neutralization and the percentage law. Arch. Virol. 83:105-111. http://dx.doi.org/10.1007/BF01310968.
45. Ge S, Yan Q, He S, Zhuang S, Niu J, Xia N. 2013. Specific primer amplification of the VP1 region directed by 5′ UTR sequence analysis: enterovirus testing and identification in clinical samples from hand-foot-and-mouth disease patients. J. Virol. Methods 193:463-469. http://dx.doi.org/10.1016/j.jviromet.2013.06.009.